| Literature DB >> 27781055 |
Jun-Xian Song1, Li Zhu2, Chong-You Lee1, Hui Ren1, Cheng-Fu Cao1, Hong Chen1.
Abstract
OBJECTIVE: To investigate whether admission time was associated with the delay of reperfusion therapy and in-hospital death in patients with ST-elevation myocardial infarction (STEMI).Entities:
Keywords: In-hospital death; Myocardial Infarction; Off-hours admission; Percutaneous coronary intervention; Total ischemic time
Year: 2016 PMID: 27781055 PMCID: PMC5067426 DOI: 10.11909/j.issn.1671-5411.2016.08.003
Source DB: PubMed Journal: J Geriatr Cardiol ISSN: 1671-5411 Impact factor: 3.327
Baseline characteristics of patients with STEMI according to admission time.
| Characteristic | Regular hours ( | Off-hours ( | |
| Males | 78 (74.3%) | 139 (75.5%) | 0.812 |
| Age, yrs | 63.2 ± 13.1 | 62.1 ± 13.4 | 0.502 |
| Medical history | |||
| Hypertension | 55 (52.4%) | 115 (62.5%) | 0.093 |
| Diabetes | 23 (21.9%) | 55 (29.9%) | 0.142 |
| Hyperlipidemia | 27 (25.7%) | 52 (28.3%) | 0.641 |
| CHD | 15 (14.3%) | 32 (17.4%) | 0.492 |
| Prior MI | 3 (2.9%) | 15 (8.2%) | 0.074 |
| Stroke | 4 (3.8%) | 23 (12.5%) | 0.015 |
| Smoking | 57 (54.3%) | 112 (60.9%) | 0.275 |
| CHD family history | 15 (14.3%) | 28 (15.2%) | 0.829 |
| SBP, mmHg | 118.1 ± 17.6 | 117.9 ± 20.1 | 0.957 |
| DBP, mmHg | 70.6 ± 12.9 | 70.7 ± 12.8 | 0.959 |
| Killip class | 0.615 | ||
| I | 86 (81.9%) | 146 (79.3%) | |
| II | 15 (14.3%) | 24 (13.0%) | |
| III | 1 (1.0%) | 5 (2.7%) | |
| IV | 3 (2.9%) | 9 (4.9%) | |
| Peak TnI, ng/dL | 39.4 (12.3, 97.0) | 51.0 (16.6, 97.0) | 0.417 |
| Peak CK-MB, U/L | 132.0 (49.8, 297.4) | 162.8 (54.7, 300.0) | 0.193 |
| CHO, mmol/L | 4.49 ± 0.94 | 4.63 ± 1.05 | 0.261 |
| TG, mmol/L | 1.42 (1.03, 2.04) | 1.53 (0.99, 2.33) | 0.225 |
| HDL-C, mmol/L | 0.93 (0.83, 1.11) | 0.95 (0.80, 1.12) | 0.568 |
| LDL-C, mmol/L | 2.94 ± 0.88 | 2.96 ± 0.98 | 0.804 |
| CRE, µmol/L | 76 (64, 86) | 74 (63, 90) | 0.540 |
| HGB, g/L | 136.8 ± 19.1 | 140.7 ± 19.4 | 0.098 |
| Number of coronary vessels | 0.422 | ||
| 1 | 23 (21.9%) | 43 (23.6%) | |
| 2 | 39 (37.1%) | 54 (29.7%) | |
| 3 | 43 (41.0%) | 85 (46.7%) | |
| LM | 10 (9.5%) | 17 (9.2%) | 0.733 |
| Culprit lesion | 0.859 | ||
| LAD | 56 (53.3%) | 106 (57.6%) | |
| LCX | 11 (10.5%) | 20 (10.9%) | |
| RCA | 37 (35.2%) | 57 (31.0%) | |
| LM | 1 (1.0%) | 1 (0.5%) | |
| IABP use | 3 (2.9%) | 6 (3.3%) | 0.849 |
| Temporary pacemaker | 2 (1.9%) | 2 (1.1%) | 0.567 |
| Aspirin | 104 (99.0%) | 182 (98.9%) | 0.914 |
| Clopidogrel | 104 (99.0%) | 182 (98.9%) | 0.914 |
| Statins | 101 (96.2%) | 165 (89.7%) | 0.049 |
| β blockers | 96 (91.4%) | 158 (85.9%) | 0.164 |
Data are presented as mean ± SD, n (%), or median (25th–75th percentile). CHD: coronary heart disease; CHO: cholesterol; CK-MB: creatine kinase-MB isoenzymes; CRE: creatinine; DBP: diastolic blood pressure; HDL-C: high-density lipoprotein cholesterol; HGB: hemoglobin; IABP: intra-aortic balloon pump; LAD: left anterior descending; LCX: left circumflex; LDL-C: low-density lipoprotein cholesterol; LM: left main; MI: myocardial infarction; RCA: right coronary artery; SBP: systolic blood pressure; TG: triglyceride; TnI: troponin I.
Treatment times for patients with STEMI according to admission time.
| Variable | Regular hours ( | Off-hours ( | |
| OTD time, min | 153.00 (61.00, 300.00) | 111.50 (60.00, 197.80) | 0.018 |
| DTB time, min | 116.00 (94.50, 168.50) | 128.50 (101.25, 170.50) | 0.336 |
| DTB time ≤ 90 min | 19.0% | 15.8% | 0.474 |
| TI time, min | 314.50(205.75, 512.50) | 263.50(191.25, 383.75) | 0.040 |
Data are presented as median (25th–75th percentile) or percent. DTB: door-to-balloon; OTD: onset-to-door; TI: total ischemic.
Baseline characteristics of patients with STEMI according to in-hospital death.
| Characteristic | All ( | In-hospital death ( | No in-hospital death ( | |
| Males | 217 (75.1%) | 5 (35.7%) | 212 (77.1%) | 0.000 |
| Age, yrs | 62.5 ± 13.3 | 78.1 ± 12.1 | 61.8 ± 12.9 | 0.000 |
| Hypertension | 170 (58.8%) | 10 (71.4%) | 160 (58.2%) | 0.326 |
| Diabetes | 78 (27.0%) | 7 (50.0%) | 71 (25.8%) | 0.047 |
| Hyperlipidemia | 79 (27.3%) | 3 (21.4%) | 76 (27.6%) | 0.611 |
| CHD | 47 (16.3%) | 3 (21.4%) | 44 (16.0%) | 0.591 |
| Stroke | 27 (9.3%) | 6 (42.9%) | 21 (7.6%) | 0.000 |
| Smoking | 169 (58.5%) | 5 (35.7%) | 164 (59.6%) | 0.076 |
| CHD family history | 43 (14.9%) | 1 (7.1%) | 42 (15.3%) | 0.599 |
| SBP, mmHg | 118.0 ± 19.2 | 113.6 ± 21.2 | 118.2 ± 19.1 | 0.387 |
| DBP, mmHg | 70.7 ± 12.8 | 66.4 ± 11.1 | 70.9 ± 12.9 | 0.206 |
| Heart rate, beats/min | 79.3 ± 15.2 | 89.1 ± 16.4 | 78.8 ± 15.0 | 0.013 |
| Peak TnI, ng/dL | 50.2 (14.0, 97.0) | 95.6 (39.1, 100.0) | 48.2 (13.9, 97.0) | 0.208 |
| Peak CK-MB, U/L | 154.5 (49.6, 300.0) | 299.0 (44.4, 310.0) | 151.1 (49.8, 299.1) | 0.107 |
| CHO, mmol/L | 4.58 ± 1.01 | 4.27 ± 1.15 | 4.59 ± 1.01 | 0.264 |
| TG, mmol/L | 1.49 (1.01, 2.17) | 1.12 (0.74, 2.30) | 1.50 (1.03, 2.16) | 0.260 |
| HDL-C, mmol/L | 0.94 (0.82, 1.11) | 0.84 (0.72, 1.06) | 0.94 (0.82, 1.12) | 0.257 |
| LDL-C, mmol/L | 2.95 ± 0.95 | 2.59 ± 0.86 | 2.97 ± 0.95 | 0.159 |
| CRE, µmol/L | 74.5 (63.0, 89.0) | 103.0 (73.5, 210.3) | 74.0 (62.0, 88.0) | 0.001 |
| HGB, g/L | 139.3 ± 19.3 | 121.4 ± 16.0 | 140.1 ± 19.1 | 0.001 |
| IABP use | 9 (3.1%) | 4 (28.6%) | 5 (1.8%) | 0.000 |
| Temporary pacemaker | 4 (1.4%) | 1 (7.1%) | 3 (1.1%) | 0.059 |
| Aspirin | 286 (99.0%) | 13 (92.9%) | 273 (99.3%) | 0.021 |
| Clopidogrel | 286 (99.0%) | 13 (92.9%) | 273 (99.3%) | 0.021 |
| Statins | 254 (87.9%) | 7 (50%) | 247 (89.8%) | 0.000 |
| β-blockers | 266 (92.0%) | 8 (57.1%) | 258 (93.8%) | 0.000 |
| TI time | 273.0 (195.8, 421.8) | 305.5 (200.8, 462.8) | 273.0 (195.0, 421.3) | 0.676 |
| DTB time | 126.0 (100.3, 169.0) | 136.0 (99.5, 173.3) | 125.5 (100.8, 167.5) | 0.924 |
| OTD time | 122.0 (60.0, 218.5) | 158.0 (70.0, 343.0) | 122.0 (60.0, 217.0) | 0.409 |
| Off-hours admission | 184 (63.6%) | 12 (85.7%) | 172 (62.5%) | 0.079 |
Data are presented as mean ± SD, n (%), or median (25th–75th percentile). CHD: coronary heart disease; CHO: cholesterol; CK-MB: creatine kinase-MB isoenzymes; CRE: creatinine; DBP: diastolic blood pressure; DTB: door-to-balloon; HDL-C: high-density lipoprotein cholesterol; HGB: hemoglobin; IABP: intra-aortic balloon pump; LDL-C: low-density lipoprotein cholesterol; OTD: onset-to-door; SBP: systolic blood pressure; TG: triglyceride; TI: total ischemic; TnI: troponin I.
Multivariate analysis of in-hospital death among patients with STEMI.
| Variable | OR | 95% CI | |
| Age | 1.100 | 1.005–1.203 | 0.039 |
| Males | 4.993 | 0.911–27.354 | 0.064 |
| Stroke | 2.309 | 0.276–19.344 | 0.440 |
| Heart rate | 1.033 | 0.994–1.073 | 0.096 |
| CRE | 1.007 | 1.001–1.012 | 0.017 |
| HGB | 0.994 | 0.952–1.037 | 0.764 |
| IABP use | 6.176 | 0.886–43.069 | 0.066 |
| Statins | 1.104 | 0.089–13.672 | 0.939 |
| β-blockers | 0.207 | 0.019–1.325 | 0.109 |
CRE: creatinine; HGB: hemoglobin; IABP: intra-aortic balloon pump; STEMI: ST-segment elevation myocardial infarction.